Zymergen to Present at Goldman Sachs Annual Global Healthcare Conference
Zymergen, a leader in biofacturing, will participate in the Goldman Sachs Annual Global Healthcare Virtual Conference on June 9th at 5:30 PM ET. The presentation can be accessed live and on-demand via the company's website. Zymergen specializes in using biology, chemistry, software, and automation to create bio-based products across various industries. This participation marks an important event for investors and stakeholders looking to understand the company's innovative approaches and market contributions.
- None.
- None.
EMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming Goldman Sachs Annual Global Healthcare Virtual Conference.
Zymergen’s management is scheduled to present on Wednesday, June 9th at 5:30 p.m. Eastern Time/2:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/.
About Zymergen
Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Investor Contact
Niraj Javeri
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
502-777-2029
FAQ
When is Zymergen's presentation at the Goldman Sachs Annual Global Healthcare Virtual Conference?
How can I access Zymergen's presentation from the Goldman Sachs conference?
What industry does Zymergen operate in?
What is the main focus of Zymergen's business?
Who to contact for investor inquiries at Zymergen?
